Researchers sought to determine whether using HRD sources for HSCT would be effective for pediatric patients with hematologic cancers compared with UCB sources.

Scientists from Johns Hopkins Medicine and eight other institutions in the United States, Africa and Europe say they have ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

The authors provided solid data that support the requirement for Msi2 in tumor growth and progression, although the study would have been strengthened by including more patient samples and additional ...

NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical company developing innovative gamma-delta (γδ) T cell therapies, today unveiled INB ...

Specifically, Auletta highlights the emerging science in stem cell transplants and cell therapies, including treatments like chimeric antigen receptor (CAR) T-cell therapy. He also discussed topics ...

A stem cell transplant (SCT), also known as a bone marrow transplant (BMT), lets doctors give higher doses of treatment to try to cure acute myeloid leukemia (AML). This treatment is intense, and not ...

Introduction: Complement system has a postulated role in endothelial problems after hematopoietic stem cell transplantation (HSCT). In this retrospective, singlecenter study we studied genetic ...

A stem cell transplant (SCT) is a common treatment for multiple myeloma, especially in people who are younger and otherwise fairly healthy. It can often help people live longer and keep the myeloma in ...